The hepatitis C virus (HCV) is the leading cause of liver transplant and hepatocellular carcinoma in the United States. However, direct-acting antiviral medications are now available and can cure the disease in over 95 percent of those treated.
The Centers for Disease Control and Prevention estimate that 75 percent of all chronic HCV infections are among adults born between 1945 and 1965. In 2016, the Commonwealth of Pennsylvania signed into law that all hospitalized patients born during this period be offered HCV screening.
Alerts in the electronic health record (EHR) have been implemented to prompt screening in the past but have been poorly utilized, with less than 20 percent of eligible patients completing screening.
We designed a stepped wedge cluster randomized trial to assess if nudges could increase patient hepatitis C screening. We defaulted screening in an admission order set within the EHR and gave clinicians the option to opt-out and not order the screening test.
This study is complete. Results are forthcoming.
Penn Medicine Division of Infectious Disease